Published in Acta Naturae on January 01, 2011
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 51.42
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Searching for genetic determinants in the new millennium. Nature (2000) 17.50
Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06
The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet (1996) 11.61
Implementing a unified approach to family-based tests of association. Genet Epidemiol (2000) 10.96
What makes a good genetic association study? Lancet (2005) 3.46
Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet (1999) 3.08
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation (1999) 2.56
Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy (1995) 2.14
Genetics of multiple sclerosis. Lancet Neurol (2004) 2.12
Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol (2006) 1.66
CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun (2001) 1.62
Analysis of complex human genetic traits: an ordered-notation method and new tests for mode of inheritance. Am J Hum Genet (1995) 1.61
Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol (2000) 1.52
Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler (2004) 1.45
Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther (2005) 1.36
Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am J Med Genet (2002) 1.28
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand (2007) 1.16
The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet (2000) 1.15
Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med Genet (2008) 1.11
A genome-wide scan in forty large pedigrees with multiple sclerosis. J Hum Genet (2007) 1.02
The role of costimulation in autoimmune demyelination. J Neuroimmunol (2000) 0.90
New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population. J Neuroimmunol (2003) 0.86
Ctla4 and multiple sclerosis in the Italian population. Exp Mol Pathol (2005) 0.84
CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J Neurol Sci (1999) 0.84
Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol (2009) 0.82
Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility. J Neuroimmunol (2001) 0.82
Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis. J Neuroimmunol (2001) 0.81
[Multiple sclerosis as a polygenic disease: an update]. Genetika (2010) 0.81
TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol Scand (2007) 0.81
CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. J Neurol Sci (2001) 0.80
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population. BMC Genet (2007) 0.80
Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis. J Neuroimmunol (2007) 0.79
Genetic analysis of multiple sclerosis in Europeans: French data. J Neuroimmunol (2003) 0.79
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. J Neuroimmunol (2003) 0.79
Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. Genes Immun (2003) 0.78
Refining the analysis of a whole genome linkage disequilibrium association map: the United Kingdom results. J Neuroimmunol (2003) 0.78
[Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene]. Mol Biol (Mosk) (1998) 0.78
Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis. J Neuroimmunol (2008) 0.77
Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels. Genes Immun (2007) 0.77
Role of interleukin 4 in Spanish multiple sclerosis patients. J Neuroimmunol (2005) 0.76
[Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)]. Mol Biol (Mosk) (2010) 0.76
Partial digestion of tRNA--aminoacyl-tRNA synthetase complexes with cobra venom ribonuclease. Biochemistry (1981) 1.52
Aminoacyl-tRNA synthetases: sone recent results and achievements. Adv Enzymol Relat Areas Mol Biol (1974) 1.28
Five patients with a recently described novel leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate. Neuropediatrics (2004) 1.14
Cloning and nucleotide sequence of the structural gene encoding for human tryptophanyl-tRNA synthetase. Gene (1991) 1.03
Tryptophanyl-tRNA synthetase from beef pancreas. Methods Enzymol (1979) 1.01
Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosis. Mult Scler (2001) 0.93
Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology (2002) 0.91
[Differential gene expression analysis by DNA microarrays technology and its application in molecular oncology]. Mol Biol (Mosk) (2003) 0.91
The human gene encoding tryptophanyl-tRNA synthetase: interferon-response elements and exon-intron organization. Gene (1993) 0.91
Autophagy: mechanisms, regulation, and its role in tumorigenesis. Biochemistry (Mosc) (2013) 0.89
A Polygenic Approach to the Study of Polygenic Diseases. Acta Naturae (2012) 0.89
Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett (2001) 0.89
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology (2002) 0.88
Bovine tryptophanyl-tRNA synthetase. A zinc metalloenzyme. Eur J Biochem (1981) 0.87
Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging. Biochemistry (Mosc) (2014) 0.87
[Complex analsis of association of inflammation genes with myocardial infarction]. Mol Biol (Mosk) (2010) 0.85
Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Mosc) (1998) 0.85
Molecular and cellular studies of tryptophanyl-tRNA synthetase using monoclonal antibodies. Evaluation of a common antigenic determinant in eukaryotic, prokaryotic and archaebacterial enzymes which maps outside the catalytic domain. Eur J Biochem (1989) 0.84
[Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women]. Mol Biol (Mosk) (2006) 0.84
[Multiple sclerosis: molecular and cellular mechanisms]. Mol Biol (Mosk) (1995) 0.83
Limited proteolysis of the tryptophanyl-tRNA synthetase. Biochim Biophys Acta (1975) 0.83
[Multiple sclerosis as a polygenic disease: an update]. Genetika (2010) 0.81
[Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism]. Kardiologiia (2008) 0.81
Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62. Autoimmunity (2009) 0.81
[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels]. Mol Biol (Mosk) (2012) 0.81
[Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians]. Mol Biol (Mosk) (2002) 0.80
Alkylation of tRNATrp in a complex with tryptophanyl-tRNA synthetase. FEBS Lett (1978) 0.80
[The use of beta-interferon-1b in children and adolescents with multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.79
[Truptophanyl tRNA synthetase. Isolation and characterization of the 2 enzyme forms]. Mol Biol (1976) 0.79
[Value of allele gene polymorphism of the inflammation system for prognosis of patients with myocardial infarction]. Kardiologiia (2012) 0.79
[Immune electron microscope determination of the localization of tryptophanyl-tRNA-synthetase in bacteria and higher eukaryotes]. Mol Biol (Mosk) (1990) 0.78
Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians. Neurology (2003) 0.78
[Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene]. Mol Biol (Mosk) (1998) 0.78
[Polymorphism of APOE gene and risk of development of the multiple sclerosis at ethnic Russians]. Mol Biol (Mosk) (2009) 0.78
[Immunochemical study of tryptophanyl-tRNA-synthetase]. Biokhimiia (1991) 0.78
Kinetic parameters of tryptophan: tRNA ligase catalyzed ATP-(32P) pyrophosphate exchange as an approach to extimation of the order of substrate binding. FEBS Lett (1975) 0.78
[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. Mol Biol (Mosk) (2012) 0.78
Tryptophanyl-tRNA synthetase: evidence for an anhydrous bond involved in the tryptophanyl enzyme formation. FEBS Lett (1978) 0.77
[Effective treatment of multiple sclerosis with rebif-22 mcg in children and adolescences: results of a long-term study]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77
[Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)]. Mol Biol (Mosk) (2015) 0.77
[Polymorphism C1444T of C-reactive protein gene and C-reactive protein concentration in blood serum of healthy people and patients with myocardial infarction]. Kardiologiia (2010) 0.77
[Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)]. Mol Biol (Mosk) (2010) 0.76
Fluorinated tryptophans as substrates and inhibitors of the ATP--(32P)PPi exchange reaction catalysed by tryptophanyl tRNA synthetase. FEBS Lett (1974) 0.76
[Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.76
Evidence for essential histidine residues in tryptophanyl-tRNA synthetase. Eur J Biochem (1978) 0.76
Transcription Factor DLX5 As a New Target for Promising Antitumor Agents. Acta Naturae (2011) 0.76
The effect of hypothermia on membrane lipids in rat neocortex. Dokl Biochem Biophys (2009) 0.76
Contribution of the TGFB1 Gene to Myocardial Infarction Susceptibility. Acta Naturae (2012) 0.76
[The risk factors for the development of multiple sclerosis in the Moscow population. II. The combination of exogenous and hereditary factors]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75
[Aggregation of tryptophanyl-tRNA synthetase depending on temperature. Study by a low-angle scatter x-ray method]. Mol Biol (Mosk) (1991) 0.75
[A search for multiple sclerosis susceptibility genes ]. Mol Biol (Mosk) (2000) 0.75
[Case of combination of Beckwith-Wiedemann syndrome with West syndrome]. Vestn Ross Akad Med Nauk (2014) 0.75
[Sanfilippo Syndrome]. Vestn Ross Akad Med Nauk (2015) 0.75
[The first results of a combined all-Russian study on clinical genetics of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2013) 0.75
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.75
[Assessment of the life quality in children with phenylketonuria]. Vestn Ross Akad Med Nauk (2014) 0.75
[The structure-function relationships in alpha-interferons. A study of the antiviral activity of mutant forms of human alpha 2-interferon]. Dokl Akad Nauk SSSR (1990) 0.75
[Genetic predisposition to multiple sclerosis as a polygenic autoimmune disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2009) 0.75
Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol (2000) 0.75
[Genetic polymorphism of a human gene locus containing the tumor necrosis factor gene: new markers of susceptibility to multiple sclerosis]. Dokl Akad Nauk (1995) 0.75
[Clinical experience of the repeated multilevel injections of the botulinum toxin type A (abobotulinum toxin A) in the spastic forms of cerebral palsy]. Vestn Ross Akad Med Nauk (2014) 0.75
[Open, non-comparative phase III clinical study to evaluate the efficacy and safety of sapropterin in patients with phenylketonuria and hyperphenylalaninemia]. Vestn Ross Akad Med Nauk (2014) 0.75
[Analysis of two segments of biallelic polymorphism at the tumor necrosis factor in patients with multiple sclerosis from the Russian population: connection with NcoI-PDGF in the first intron of the lymphotoxin alpha gene]. Mol Biol (Mosk) (1999) 0.75
[Clinical genetics of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75
[Genetic predisposition factors for multiple sclerosis (based on the data from genotyping patients of the Russian ethnic group)]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75
[Polymorphism of length of tetranucleotide repeat from the 5'-side from the myelin basic protein gene in multiple sclerosis in Russians]. Mol Biol (Mosk) (2004) 0.75
[Evaluation of physical development in children with classical phenylketonuria]. Vopr Pitan (2015) 0.75